Skip to content

Effect analysis of repeated transcranial magnetic stimulation of cerebellar on dysphagia after stroke

Bilateral cerebellar intermittent theta burst stimulation for dysphagia after stroke: a randomized, double-blind, sham-controlled, clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055414
Enrollment
Unknown
Registered
2022-01-09
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Group 1:true bilateral cerebellar iTBS
Group 2:sham bilateral cerebellar iTBS

Sponsors

Yuebei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Stroke patients with first onset confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); 2. Dysphagia measured by fibreoptic endoscopic evaluation of swallowing (FEES) or a video fluoroscopic swallowing study (VFSS); 3. Stable vital signs with a duration of disease of more than one week and less than six months; 4. Aged 18 to 85 years, male or female; 5. Clear consciousness and a stable condition, able to cooperate with various examinations and rehabilitation training; and 6. Consent obtained from the patient and their family, and informed consent was signed.

Exclusion criteria

Exclusion criteria: 1. Dysphagia not caused by stroke; 2. Acute stroke in the bleeding stage; 3. Cognitive dysfunction and mental illness that prevented cooperation with the treatment; and 4. Contraindications for rTMS, such as metal stents or pacemakers installed in the heart, metal implants in the skull, epilepsy, cochlear implants, etc.; 5. A malignant tumour or a bleeding tendency.

Design outcomes

Primary

MeasureTime frame
Fiberoptic Endoscopic Dysphagia Severity Scale;Penetration/Aspiration Scale;Standardized Swallowing Assessment;Functional Oral Intake Scale;

Secondary

MeasureTime frame
The occurrence of adverse events;

Countries

China

Contacts

Public ContactHuiyu Liu

Yuebei People's Hospital

1045273455@qq.com+86 13922599818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026